TipRanks
Santhera Pharmaceuticals Holding (CH:SANN)
:SANN
Switzerland Market
SANN
Santhera Pharmaceuticals Holding
RESEARCH TOOLSreports
Want to see CH:SANN full AI Analyst Report?

Santhera Pharmaceuticals Holding (SANN) Income Statement

6 Followers

Santhera Pharmaceuticals Holding Income Statement

Last quarter (Q2 2026), Santhera Pharmaceuticals Holding's total revenue was CHF48.33M, an increase of 242.43% from the same quarter last year. In Q2, Santhera Pharmaceuticals Holding's net income was CHF-21.53M. See Santhera Pharmaceuticals Holding’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Dec 23Mar 23Dec 21
Total Revenue
CHF 77.19MCHF 39.12MCHF 103.41MCHF 7.47MCHF -1.59M
Gross Profit
CHF 14.47MCHF 22.96MCHF 100.18MCHF 3.88MCHF -5.36M
Operating Expenses
CHF 52.28MCHF 56.69MCHF 31.34MCHF 55.86MCHF 51.53M
Depreciation and Amortization
CHF 5.69MCHF 5.65MCHF 3.04MCHF 3.65MCHF 3.72M
EBITDA
CHF -32.13MCHF -15.89MCHF 79.17MCHF -46.78MCHF -34.57M
Operating Income
CHF -37.82MCHF -33.38MCHF 68.84MCHF -51.98MCHF -56.89M
Other Income/Expenses
CHF -11.23MCHF -8.28MCHF -14.02MCHF -18.64MCHF 2.17M
Pretax Income
CHF -49.05MCHF -41.66MCHF 54.82MCHF -70.62MCHF -54.72M
Net Income
CHF -49.24MCHF -41.97MCHF 54.78MCHF -71.08MCHF -55.53M
Per Share Metrics
Basic EPS
CHF -3.78CHF -3.69CHF 5.18CHF -11.67CHF -16.25
Diluted EPS
CHF -3.78CHF -3.69CHF 5.01CHF -11.67CHF -16.25
Weighted Average Shares Outstanding
 13.01M 11.38M 10.58M 6.09M 3.42M
Weighted Average Shares Outstanding (Diluted)
 13.01M 11.38M 10.92M 6.09M 3.42M
Currency in CHF

Santhera Pharmaceuticals Holding Earnings and Revenue History